Editas Medicine, Inc. (EDIT)
1.82
+0.16
(+9.31%)
USD |
NASDAQ |
Feb 06, 16:00
1.83
+0.01
(+0.55%)
After-Hours: 20:00
Editas Medicine EPS Diluted (Quarterly) : -0.2788 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.1489 |
| Arcutis Biotherapeutics, Inc. | 0.0558 |
| Biogen, Inc. | -0.3333 |
| Daré Bioscience, Inc. | -0.2793 |
| Cogent Biosciences, Inc. | -0.5884 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.12M |
| Revenue (Quarterly) | 7.543M |
| Total Expenses (Quarterly) | 32.66M |
| Enterprise Value | 90.74M |
| Gross Profit Margin (Quarterly) | 90.44% |
| Profit Margin (Quarterly) | -333.0% |
| Earnings Yield | -130.6% |
| Normalized Earnings Yield | -94.00 |